Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
7.15
+0.14 (2.00%)
Aug 19, 2026, 4:00 PM EDT - Market closed
Kyntra Bio Market Cap
Kyntra Bio has a market cap or net worth of $28.95 million as of August 20, 2026. Its market cap has decreased by -36.65% in one year.
Market Cap
28.95M
Enterprise Value
-62.37M
1-Year Change
-36.65%
Ranking
Category
Stock Price
$7.15
ChartMarket Cap Chart
Since November 14, 2014, Kyntra Bio's market cap has decreased from $1.22B to $28.95M, a decrease of -97.64%. That is a compound annual growth rate of -27.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 29.00M | -18.31% |
| Dec 31, 2025 | 35.50M | -33.52% |
| Dec 31, 2024 | 53.40M | -38.76% |
| Dec 29, 2023 | 87.20M | -94.21% |
| Dec 30, 2022 | 1.51B | 15.15% |
| Dec 31, 2021 | 1.31B | -61.28% |
| Dec 31, 2020 | 3.38B | -9.80% |
| Dec 31, 2019 | 3.74B | -4.85% |
| Dec 31, 2018 | 3.93B | 1.17% |
| Dec 29, 2017 | 3.89B | 187.60% |
| Dec 30, 2016 | 1.35B | -27.68% |
| Dec 31, 2015 | 1.87B | 22.78% |
| Dec 31, 2014 | 1.52B | 24.27% |
| Nov 14, 2014 | 1.22B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NextCure | 30.44M |
| Lite Strategy | 30.01M |
| BeyondSpring | 29.53M |
| BriaCell Therapeutics | 29.48M |
| IGC Pharma | 29.40M |
| Dyadic International | 27.84M |
| CEL-SCI | 27.79M |
| Genenta Science | 27.60M |